BFLY vs GIPL vs ZTS Stock Comparison

Butterfly Network, Global Innovative Platforms and Zoetis Prices as of Nov 2, 2026 Peers: Industry group
1 more company in this comparison (QDEL) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$6.14 -31.2% 1M +128.3% 1Y
Market cap
$1.78B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
ZTS Zoetis Inc.
$83.18 +19.4% 1M -42.3% 1Y
Market cap
$36.54B
P/E
14.0x
Revenue (TTM)
$9.52B
Div. yield
0.02%
Animal Health Healthcare
4 wins

Head to Head

8 decided of 12

Zoetis leads on 4 of the 12 questions below (Zoetis 4, Butterfly Network 3, Global Innovative Platforms 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYGIPLZTSLeader
Larger companyMarket capitalisation $1.78B $2.49M $36.54B ZTS
Cheaper on earningsLower P/E, profitable companies only -33.2x -3.6x 14.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 14.2x –
Faster revenue growthRevenue growth, trailing twelve months +39.4% — +1.5% BFLY
More profitableNet margin, trailing twelve months -43.6% -361.7% 27.5% ZTS
Better return on capitalReturn on invested capital — — 23.4% –
Less leveragedLower net debt / EBITDA — 0.4x 1.8x GIPL
Higher dividend yieldTrailing dividend yield 0.00% — 0.02% –
Better 1-year returnPrice return, last 12 months +128.3% -93.8% -42.3% BFLY
Better 5-year returnAnnualised price return, 5 years -10.4%/yr -60.2%/yr -17.0%/yr BFLY
Less volatileAnnualised volatility, 1 year 112.8% 356.0% 41.0% ZTS
Higher overall scoreMean of the five percentile scores vs peers 49/100 41/100 72/100 ZTS

Percentile Scorecard

BFLYGIPLZTS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYGIPLZTS
Valuation 31 #158 of 227 25 #470 of 623 87 #80 of 623
Growth 87 #29 of 220 27 #439 of 601 51 #294 of 601
Profitability 39 #128 of 209 39 #337 of 553 96 #23 of 553
Financial Health 57 #105 of 240 98 #12 of 654 34 #430 of 654
Shareholder Returns 30 #97 of 138 16 #310 of 367 89 #41 of 367
Overall 49 41 72
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • GIPL ranked among 671 companies in Pharmaceuticals and Biotechnology
  • ZTS ranked among 671 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYGIPLZTSSPY
1 month -31.2%-90.0%+19.4% -2.3%
3 months -25.2%-90.0%+7.9% -0.7%
6 months +26.6%-90.4%-26.2% +4.8%
Year to date +61.6%-54.5%-33.9% +10.3%
1 year +128.3%-93.8%-42.3% +10.3%
3 years +448.2%-95.2%-48.7% +73.0%
3 years, per year +76.4%-63.8%-20.0% +20.1%
5 years -42.3%-99.0%-60.6% +61.9%
5 years, per year -10.4%-60.2%-17.0% +10.1%
10 years —-97.9%+66.0% +258.6%
10 years, per year —-32.1%+5.2% +13.6%

Risk

MeasureBFLYGIPLZTSSPY
Volatility, 1Y 112.8%356.0%41.0% 12.8%
Downside volatility, 1Y 94.2%2,018.7%49.5% 12.8%
Beta vs S&P 500, 1Y 3.094.870.48 1.00
Return / volatility, 1Y 1.14-0.26-1.03 0.80
Max drawdown, 5Y -93.4%-99.0%-72.0% -25.4%
From 52-week high -38.2%-94.9%-42.4% -3.5%
52-week high $9.94$0.99$144.35 $779.14
52-week low $1.97$0.05$69.12 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYGIPLZTS
P/E now vs peer median -30.0xmedian 28.4x -3.6xmedian 17.4x 13.3xmedian 17.4x
P/S now vs peer median 11.9xmedian 3.0x 13.3xmedian 8.9x 3.6xmedian 8.9x
EV/EBITDA now vs peer median -26.3xmedian 18.0x -3.6xmedian 17.0x 10.3xmedian 17.0x
P/FCF now vs peer median -53.0xmedian 25.0x -3.2xmedian 21.4x 14.9xmedian 21.4x
P/B now vs peer median 7.9xmedian 2.3x 4.7xmedian 2.1x 10.9xmedian 2.1x
PEG now vs peer median -1.00median 0.93 -0.06median 0.35 1.41median 0.35

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYGIPLZTS
Revenue $123.25M $187.20K $9.52B
Gross profit $86.60M – $6.81B
Operating income -$57.83M -$677.04K $3.59B
Net income -$53.69M -$677.04K $2.62B
Free cash flow -$27.55M -$766.04K $2.32B
R&D $39.57M $377.99K $722.00M
EPS (diluted) $-0.20 $-0.02 $6.26
Cash & equivalents $122.30M $244.24K $1.48B
Total debt – $5.62K $9.05B
Shares (diluted) 262.10M 44.54M 417.70M
Enterprise value $1.25B $1.88M $28.39B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYGIPLZTS
P/E -30.0x -3.6x 13.3x
P/FCF -53.0x -3.2x 14.9x
P/Operating cash flow -62.5x -3.5x 12.1x
P/S 11.9x 13.3x 3.6x
P/B 7.9x 4.7x 10.9x
P/Tangible book 8.2x 4.7x 15.4x
EV/EBITDA -26.3x -3.6x 10.3x
EV/EBIT -23.2x -3.3x 11.7x
EV/Revenue 10.9x 12.0x 4.4x
EV/FCF -48.6x -2.9x 18.1x
EV/Operating cash flow -57.2x -3.2x 14.7x
PEG (3Y EPS CAGR) -1.00 -0.06 1.41

Growth

14 metrics
MetricBFLYGIPLZTS
Revenue growth (1Y) 39.4% – 1.5%
Revenue CAGR (3Y) 21.7% – 5.0%
Gross profit growth (1Y) 126.4% – 1.8%
Gross profit CAGR (3Y) 30.5% – 5.7%
Operating income growth (1Y) 33.5% -20.9% -0.1%
Operating income CAGR (3Y) 26.9% -51.6% 5.2%
Net income growth (1Y) 32.8% -20.9% 0.6%
Net income CAGR (3Y) 24.2% -51.6% 5.7%
EPS growth (1Y) 35.4% -9.8% 7.7%
EPS CAGR (3Y) 30.0% 63.5% 9.4%
Operating cash flow growth (1Y) 5.8% 15.8% -4.6%
Operating cash flow CAGR (3Y) 41.1% -96.8% 12.4%
Free cash flow growth (1Y) -0.1% 9.2% 2.1%
Free cash flow CAGR (3Y) 38.8% -101.8% 21.7%

Profitability

14 metrics
MetricBFLYGIPLZTS
Gross margin 70.3% – 71.5%
EBITDA margin -41.4% -333.4% 42.8%
Operating margin -46.9% -361.7% 37.7%
Pretax margin -43.5% -361.7% 34.4%
Net margin -43.6% -361.7% 27.5%
FCF margin -22.4% -409.2% 24.3%
Operating cash flow margin -19.0% -379.8% 29.8%
Return on equity -28.7% -120.8% 82.0%
Return on assets -18.8% -119.7% 17.3%
Return on invested capital – – 23.4%
Return on capital employed -26.6% -121.4% 27.5%
Asset turnover 0.4x 0.3x 0.6x
Cash conversion (OCF / net income) 0.4x 1.1x 1.1x
Stock comp / revenue 20.8% – 1.0%

Financial Health

11 metrics
MetricBFLYGIPLZTS
Debt / assets – 1.0% 60.0%
Debt / equity – 0.0x 2.9x
Net debt / EBITDA – 0.4x 1.8x
Debt / FCF – 0.0x 3.9x
Liabilities / assets 36.0% 1.4% 79.1%
Equity / assets 64.0% 98.6% 20.9%
Interest coverage -46.8x – 15.1x
Current ratio 3.6x 34.7x 3.1x
Quick ratio 2.3x 33.2x 1.6x
Cash ratio 1.8x 31.3x 0.8x
Altman Z-score 4.51 183.95 4.85

Shareholder Returns

7 metrics
MetricBFLYGIPLZTS
Dividend yield – – 2.5%
Net buyback yield -0.6% -32.1% 10.6%
Shareholder yield -0.6% -32.1% 13.1%
Payout ratio (earnings) – – 34.0%
Payout ratio (FCF) – – 38.4%
Dividend growth (1Y) – – 6.1%
Dividend CAGR (3Y) – – 10.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYGIPLZTS
Forward P/E – – 14.2xFY2026
EPS, next fiscal year $-0.10FY2026 – $5.86FY2026
EPS growth, next FY – – -8.6%FY2026
EPS growth, the year after – – +13.0%
Revenue, next fiscal year $114.50MFY2026 – $9.57BFY2026
Revenue growth, next FY +17.3%FY2026 – +1.0%FY2026
Revenue growth, the year after +26.0% – -7.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYGIPLZTS
Held by institutions 59.9% – 94.7%
Institutions holding 247 – 1,419
Change in shares held, QoQ +13.9% – -2.6%
Institutions buying 143 – 675
Institutions selling 59 – 583
Buyers to sellers 2.42 – 1.16

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYGIPLZTS
BFLY 1.00 0.10 0.16
GIPL 0.10 1.00 -0.01
ZTS 0.16 -0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, GIPL and ZTS?

Zoetis (ZTS) is the largest by market capitalisation: Butterfly Network (BFLY) $1.78B, Global Innovative Platforms (GIPL) $2.49M, Zoetis (ZTS) $36.54B.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Zoetis (ZTS) +1.5%.

Which company is more profitable?

Zoetis (ZTS) has the highest net margin (Butterfly Network (BFLY) -43.6%, Global Innovative Platforms (GIPL) -361.7%, Zoetis (ZTS) 27.5%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +128.3%, Global Innovative Platforms (GIPL) -93.8%, Zoetis (ZTS) -42.3%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -10.4%/yr, Global Innovative Platforms (GIPL) -60.2%/yr, Zoetis (ZTS) -17.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Butterfly Network (BFLY) 0.00%, Zoetis (ZTS) 0.02%. Butterfly Network (BFLY) and Global Innovative Platforms (GIPL) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Zoetis (ZTS) has been the steadiest (Butterfly Network (BFLY) 112.8%, Global Innovative Platforms (GIPL) 356.0%, Zoetis (ZTS) 41.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, GIPL and ZTS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Zoetis (ZTS) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.